Haya Taitel
CIK: 0001979599
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENTX
Entera Bio Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 7, 2026ENTX
Entera Bio Ltd.
Award(A)Direct20.8K shares- - Feb 10, 2026ENTX
Entera Bio Ltd.
Purchase(P)Direct7.5K shares at avg. $1.48$11K - Jan 1, 2026ENTX
Entera Bio Ltd.
Award(A)Direct26.3K shares- - Jan 15, 2025ENTX
Entera Bio Ltd.
Award(A)Direct6.9K shares- - Oct 2, 2024ENTX
Entera Bio Ltd.
Award(A)Direct7.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 | ENTX Entera Bio Ltd. | Award(A) | 20,790 | - | $0 | Direct |
| Feb 10, 2026 | ENTX Entera Bio Ltd. | Purchase(P) | 7,500 | $1.48 | $11,100 | Direct |
| Jan 1, 2026 | ENTX Entera Bio Ltd. | Award(A) | 26,329 | - | $0 | Direct |
| Jan 15, 2025 | ENTX Entera Bio Ltd. | Award(A) | 6,922 | - | $0 | Direct |
| Oct 2, 2024 | ENTX Entera Bio Ltd. | Award(A) | 7,278 | - | $0 | Direct |
1-5 of 5 transactions
About Taitel Haya
Taitel Haya (SEC CIK 0001979599) files insider reports with the SEC as Director of Entera Bio Ltd. (ENTX).
Signal8 holds 5 ownership filings by Taitel Haya, all Form 4s, filed between Oct 4, 2024 and Aug 7, 2026. Those filings report 5 transactions, from Oct 2, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Taitel Haya's filings is in JERUSALEM.
Recent filings by Taitel Haya
- Aug 7, 2026: Grant or award of ENTX shares (Form 4, code A).
- Feb 10, 2026: Open-market purchase of ENTX shares (Form 4, code P).
- Jan 1, 2026: Grant or award of ENTX shares (Form 4, code A).
- Jan 15, 2025: Grant or award of ENTX shares (Form 4, code A).
- Oct 2, 2024: Grant or award of ENTX shares (Form 4, code A).
Other insiders filing for Entera Bio Ltd. (ENTX)
- Camisasca Riccardo Paolo, Chief Medical Officer
- Malca Yonatan, Director
- Ellis Sean, Director
- Yaacov-Garbeli Dana, Chief Financial Officer
- Galitzer Hillel, Chief Operating Officer
- Burshtein Gregory, Chief of R&D